The 10 Companies Booming in Healthcare Sector

Eclectic Services
Accutest provides services across
various verticals like
Bioavailability/Bioequivalence
(BA/BE) studies for Generic Industry,
Clinical Development Services (CDS)
for New Chemical Entities, and Bioanalytical
Services to Biologics/Biosimilar
drug molecules. Speaking
about all that they offer to the clients,
Dr. Sawant says, “At Accutest, we
assist Pharma industries in their drug
development life cycle by evaluating its
safety, efficacy, ADME character, and
quality aspect before the product is
certified as appropriate for marketing.
As a CRO, we become a part of the
pharmaceutical organizations in their
research program to evaluate
medicines for their quality and test on
human population for the safety,
effectiveness, and blood levels of the
drug after they are consumed.”
Accutest has undoubtedly emerged to
be the preferred CRO for first-to-file
studies. The company also focuses on
Phase II-IV clinical trials services for
drug development companies in India
and abroad. It conducts clinical trials
as per Standard Operating Procedures
(SOPs) developed in-house, in
accordance with ICH GCP guidelines
and Indian GCP to accomplish and
efficiently cater to requirements of its
clients.
Accutest Biologics, its subsidiary, is a
one-stop solution for analytical and
bio-analytical services from early stage
characterization to the late stage
clinical evaluation of biologics.
Bioanalytical services include
Pharmacokinetics, Pharmacodynamics,
and Immunogenicity assessment of
biologics, bio-therapeutics, biosimilars,
vaccines, and non-biological complex
drugs using high-end assay formats
like ELISA, MSD, and GYROS. It also
provides in vitro activity/potency and
bioassays services for evaluating the
biological activities besides toxic
kinetics and related services.
What sets It Apart?
Being in clinical research field for 21
years now, Accutest is setting a niche
in the industry with its unmatched
expertise and services. The success
stories of Accutest and accreditations
from global regulators, like US FDA,
WHO, EMA, ANVISA, DCGI, MCC
and other prominent authorities, stand
as a testament to its unwavering
commitment to international quality
standards and operating procedures.
Recently, the company received the
prestigious OECD GLP certification by
NGCMA. Accutest is the first and only
independent biologics testing facility in
India to be honored with this
international accreditation. The
company constantly strives to reinvent
itself, along with providing advanced
services to its clients.
Incredible Team
Accutest takes great pride in its
dynamic team, which understands
customer requirements and gives
optimal solutions. Dr. Sawant asserts,
“We have a rich pool of well qualified
and dedicated professionals, these are
our assets. Their rich experience and
involvement during clients’ drug
development program gives clients the
confidence to outsource their clinical
development needs. Timely delivery,
our regulatory history, global reach,
staff and our ability to work hand-inhand
with the clients are some of our
value propositions which set us apart
from other competitors in the market.”
Perfect R&D Partner
Accutest is the partner of choice for
generic drug manufacturers looking to
execute BA/BE studies with a high
degree of quality and speed, at
competitive prices. It has one of the
largest data banks of 41,000+
volunteers along with strong regulatory
track records. The company’s state-ofthe-art
infrastructure comprises of
more than 400 beds, 38 LCMS-MS,
and 700+ validated methods, enabling
it to serve the clients with ease and
quality. Acutest is rendering numerous
benefits to its clients by catering to
their complete, complex, and cross
functional service requirements, under
one roof with ease and expertise.
‘‘ We offer an
umbrella
contract-based
R&D services to
our industry
partners with a
focus on quality
and quick
turnaround
time
‘‘
| June 2019 | 33